rb 6145 has been researched along with arginine in 1 studies
| Studies (rb 6145) | Trials (rb 6145) | Recent Studies (post-2010) (rb 6145) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 38 | 0 | 2 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | rb 6145 (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, GE; Butler, SA; Cole, SM; Sansom, JM; Stratford, IJ; Szabo, C; Thiemermann, C; Wood, PJ | 1 |
1 other study(ies) available for rb 6145 and arginine
| Article | Year |
|---|---|
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine.
Topics: Animals; Arginine; Carcinoma; Cell Hypoxia; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Female; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C3H; Nitroarginine; Nitroimidazoles; Phosphates; Prodrugs; Sarcoma, Experimental | 1994 |